All SEC Filings :: Navidea Biopharmaceuticals, Inc. (NAVB)

Filing Type:

Year:

Date	Form	Description	Pages
08/20/12	8-K	Current report filing Documents EX-99.1	9
08/15/12	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-5 EX-23.(B) EX-24	10
08/09/12	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	39
08/07/12	8-K	Current report filing Documents EX-99.1	9
08/06/12	8-K	Current report filing Documents EX-10.1 EX-10.2 EX-99.1	53
07/31/12	8-K	Current report filing Documents EX-10.1 EX-10.2 EX-99.1	55
07/27/12	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents EX-1	8
07/11/12	ARS	Annual report to security holders	1
07/10/12	DEF 14A	Definitive proxy statements	62
06/07/12	8-K	Current report filing Documents EX-10.1	12